The Contact PVI Study: Use of Tissue Contact Data to Guide Atrial Fibrillation Ablation

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 148 participants.

Also called NCT01629056

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 148 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01629056
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01629056. Randomized; single masking; primary purpose treatment. Start 2012-01 (registry gives no type); primary completion 2013-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Contact PVI Study: Use of Tissue Contact Data to Guide Atrial Fibrillation Ablation
Intervention (Procedure)
ablation
Intervention (Procedure)
RF ablation
Lead sponsor
Oxford University Hospitals NHS Trust (class: other)

Record details

Record id
cardio:ct-nct01629056
Content hash
d4f57c5ac9e63afea0add97d6da2f475c5abef70a92914ec2d099266305e7a2f